Biosynthesis of Three Chalcone β-D-glucosides by Glycosyltransferase from Bacillus subtilis ATCC 6633 |
Fei, Yinuo
(State Key Laboratory of Natural Medicines, China Pharmaceutical University)
Shao, Yan (State Key Laboratory of Natural Medicines, China Pharmaceutical University) Wang, Weiwei (State Key Laboratory of Natural Medicines, China Pharmaceutical University) Cheng, Yatian (State Key Laboratory of Natural Medicines, China Pharmaceutical University) Yu, Boyang (State Key Laboratory of Natural Medicines, China Pharmaceutical University) He, Xiaorong (School of Engineering, China Pharmaceutical University) Zhang, Jian (State Key Laboratory of Natural Medicines, China Pharmaceutical University) |
1 | Lowery JJ, Yeomans L, Keyari CM, Davis P, Porreca F, Knapp BI, et al. 2007. Glycosylation improves the central effects of DAMGO. Chem. Biol. Drug Des. 69: 41-47. DOI |
2 | Pandey RP, Bashyal P, Parajuli P, Yamaguchi T, Sohng JK. 2019. Two Trifunctional Leloir Glycosyltransferases as biocatalysts for natural products glycodiversification. Org. Lett. 21: 8058-8064. DOI |
3 | Yan Y, Li Z, Koffas MAG. 2008. High-yield anthocyanin biosynthesis in engineered Escherichia coli. Biotechnol. Bioeng. 100: 126-140. DOI |
4 | Cheng Y, Zhang J, Shao Y, Xu Y, Ge H, Yu B, et al. 2019. Enzymecatalyzed glycosylation of curcumin and its analogues by glycosyltransferases from Bacillus subtilis ATCC 6633. Catalysts 9: 734. DOI |
5 | Mao Z, Shin H-D, Chen RR. 2006. Engineering the E. coli UDP-Glucose synthesis pathway for oligosaccharide synthesis. Biotechnol. Prog. 22: 369-374. DOI |
6 | Gomes MN, Muratov EN, Pereira M, Peixoto JC, Rosseto LP, Cravo PVL, et al. 2017. Chalcone derivatives: Promising starting points for drug design. Molecules 22: 1210. DOI |
7 | Dai L, Li J, Yao P, Zhu Y, Men Y, Zeng Y, et al. 2017. Exploiting the aglycon promiscuity of glycosyltransferase Bs-YjiC from Bacillus subtilis and its application in synthesis of glycosides. J. Biotechnol. 248: 69-76. DOI |
8 | Al-Mamary M, Al-Mikhlafi SA, Jaadan B. 2014. Synthesis and biological activities of some chalcone derivatives. Int. J. Chem. Pharm. Sci. 5: 8. |
9 | Hofer B. 2016. Recent developments in the enzymatic O-glycosylation of flavonoids. Appl. Microbiol. Biotechnol. 100: 4269-4281. DOI |
10 | Xiao J, Muzashvili TS, Georgiev MI. 2014. Advances in the biotechnological glycosylation of valuable flavonoids. Biotechnol. Adv. 32: 1145-1156. DOI |
11 | Pinho-Ribeiro FA, Hohmann MSN, Borghi SM, Zarpelon AC, Guazelli CFS, Manchope MF, et al. 2015. Protective effects of the flavonoid hesperidin methyl chalcone in inflammation and pain in mice: Role of TRPV1, oxidative stress, cytokines and NF-κB. Chem. Biol. Interact. 228: 88-99. DOI |
12 | Manna T, Pala K, Janaa K, Misraa AK. 2019. Anti-cancer potential of novel glycosylated 1,4-substituted triazolylchalcone derivatives. Bioorg. Med. Chem. Lett. 29: 126615. DOI |
13 | Orlikova B, Tasdemir D, Golais F, Dicato M, Diederich M. 2011. Dietary chalcones with chemopreventive and chemotherapeutic potential. Genes Nutr. 6: 125-147. DOI |
14 | Ma Y, He Y, Yin T, Chen H, Gao S, Chalcone Derivatives M. 2018. Metabolism of phenolic compounds in LPS-stimulated Raw264.7 Cells can impact their anti-inflammatory efficacy: Indication of hesperetin. J. Agric. Food Chem. 66: 6042-6052. DOI |
15 | Sangpheak K, Mueller M, Darai N, Wolschann P, Suwattanasophon C, Ruga R, et al. 2019. Computational screening of chalcones acting against topoisomerase IIα and their cytotoxicity towards cancer cell lines. J. Enzyme Inhib. Med. Chem. 34: 134-143. DOI |
![]() |